Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
CJEM ; 16(4): 304-13, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25060084

RESUMO

OBJECTIVE: To evaluate the efficacy and safety of a simple linear midazolam-based protocol for the management of impending status epilepticus in children up to 18 years of age. METHODS: This is a descriptive, quality assessment, retrospective chart review of children presenting with the chief complaint of seizure disorder in the emergency department (ED) of a tertiary care pediatric hospital and a triage category of resuscitation or urgent from April 1, 2009, to August 31, 2011. In children with at least one seizure episode in the ED treated according to the linear protocol, three main outcomes were assessed: compliance, effectiveness, and complications. RESULTS: Of the 128 children meeting the above study criteria, 68 had at least one seizure episode in the ED, and treatment was required to terminate at least one seizure episode in 46 of 68 patients (67.6%). Fifty-five seizure episodes were treated in the 46 patients: 51 of 55 seizure episodes were treated with midazolam (92.7%) and 4 of 55 with lorazepam or diazepam (7.3%). Of those treated with midazolam, 86.3% (44 of 51) were successfully treated with one or two doses of midazolam. The median seizure duration for all treated patients was 6 minutes. Of the 42 patients treated with midazolam, 7 required either continuous positive airway pressure or intubation, and two patients were treated for hypotension. One patient died of pneumococcal meningitis. CONCLUSION: This simple linear protocol is an effective and safe regimen for the treatment of impending status epilepticus in children.


Assuntos
Protocolos Clínicos , Diazepam/uso terapêutico , Serviço Hospitalar de Emergência/normas , Midazolam/uso terapêutico , Garantia da Qualidade dos Cuidados de Saúde/métodos , Estado Epiléptico/tratamento farmacológico , Adolescente , Anticonvulsivantes/uso terapêutico , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Hipnóticos e Sedativos/uso terapêutico , Lactente , Masculino , Estudos Retrospectivos , Fatores de Tempo
3.
BMJ Case Rep ; 20132013 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-23391944

RESUMO

Cow milk allergy (CMA) is a common problem affecting 2-3% of children and is the most prevalent food allergy in infancy. Infantile colic is also a common problem in the first year of life. A frequent practice among physicians is to recommend a dairy-free diet to breast-feeding mothers and infants in cases of infantile colic. However, recent studies suggest that late introduction of potentially allergenic foods may increase the risk of developing a life-threatening food allergy. We describe two infants managed with dairy-free diet to control symptoms of colic in whom CMA developed. It is possible that unnecessary cow milk restriction may have contributed to the development of food allergy in these infants.


Assuntos
Cólica/dietoterapia , Hipersensibilidade Imediata/etiologia , Fórmulas Infantis , Hipersensibilidade a Leite/etiologia , Animais , Humanos , Lactente , Masculino , Leite/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA